American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast CancerBruce E. Hillner, David G. Pfister, James N. Ingle et al.|Journal of Clinical Oncology|2000Cited by 383
A Phase I/II Study of Arsenic Trioxide/Bortezomib/Ascorbic Acid Combination Therapy for the Treatment of Relapsed or Refractory Multiple MyelomaJames R. Berenson, Howard Yeh, Jeffrey Matous et al.|Clinical Cancer Research|2007Cited by 123
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single‐arm studyJames R. Berenson, Regina A. Swift, Marshall S. Flam et al.|British Journal of Haematology|2006Cited by 83
Arsenic Compounds in the Treatment of Multiple Myeloma: A New Role for a Historical RemedyJames R. Berenson, Howard Yeh|Clinical Lymphoma & Myeloma|2006Cited by 57
Treatment for Myeloma Bone DiseaseHoward Yeh, James R. Berenson|Clinical Cancer Research|2006Cited by 47